-
摘要:
放射治疗是乳腺癌的重要治疗手段，由于左乳与心脏位置毗邻，设计照射野时常不能完全避开心脏。乳腺癌放射治疗增加了患缺血性心脏病、心包炎和瓣膜病的风险。年轻、高体重指数（body mass index, BMI）、肿瘤位于中央象限和胸骨旁区域与心脏受到高剂量辐射有关。放疗心脏毒性与放疗技术有很大关系，对于左乳切除术后放疗，多野调强适形放疗（IMRT）能够平衡靶区覆盖和正常组织受量，而左乳保乳术后放疗，采用双弧度容积旋转调强（VMAT）较多野IMRT更具优势。相比全乳照射，加速部分乳腺照射能够显著降低心脏剂量；而对于需要照射区域淋巴结的患者，采用容积旋转调强或螺旋断层放疗在减少心脏受量方面则显示出优势。相比自由呼吸，深吸气屏气放疗能够显著减少心脏和冠状动脉左前降支剂量；尤其是对于胸壁+区域淋巴结（包括内如淋巴结）放疗的患者采用深吸气屏气（deep inspiration breath hold, DIBH）放疗获益更多，而对于保乳术后仍为大乳腺的患者，采用俯卧位能减少心脏毒性。另外，左乳放疗期间同步曲妥珠单抗靶向治疗、芳香化酶抑制剂（aromatase inhibitors, AI）会影响心脏事件的发生。基于上述因素，在给左侧乳腺癌患者制定放疗计划时，应结合患者年龄、BMI、原发肿瘤位置、体型、术后乳腺大小、是否需要区域淋巴结照射，根据现有放疗设备，给予最优的放疗方案，同时减少增加心脏毒性的同步治疗，从而最大程度减少治疗导致的心脏不良反应。
Abstract:Radiotherapy (RT) is an important treatment for breast cancer. As the left breast is adjacent to heart, heart irradiation cannot be completely avoided. Radiotherapy on breast cancer increases the risk of ischemic heart disease, pericarditis and valvular disease. Tumor location and treatment choices influence cardiac dose with complex interactions. Radiation technology plays an important role in cardiac toxicity of radiotherapy. Multi-field IMRT may be the optimal one which can balance PTV coverage and organ at risk sparing for left-sided breast cancer after mastectomy; as to the patients after breast-conserving surgery irradiation, volumetric-modulated arc therapy (VMAT) offer certain dosimetric advantages over fixed-field IMRT plans. Compared with whole breast irradiation, partial breast irradiation shows a significant reduction in radiation dose for the heart. As to lymph node-positive left-sided breast cancer patients, VMAT or tomotherapy retains target homogeneity and coverage and allows maximum doses to organs at risk to be reduced; deep inspiration breath hold results in a significant reduction in radiation dose to the heart and left anterior descending coronary artery compared with an free breathing, especially for the patients who need to irradiate chest wall and regional lymph node; and for some patients with large breast after surgery, prone setup can significantly reduce the amount of heart volume. Moreover, left-sided radiotherapy concurrent with trastuzumab or AI increases the cardiac toxicity risk. In conclusion, left-sided breast radiotherapy plan needs to consider patients' age, BMI, primary tumor location, size, postoperative breast size, whether need regional lymph node radiation; giving the optimal radiotherapy plan according to the existing radiation therapy equipment, at the same time, reducing the synchronous cardiac toxicity increasing treatment, so as to minimize cardiac adverse event.
-
Key words:
- Breast cancer /
- Radiotherapy /
- Cardiac toxicity
-
-
[1] Chen W, Zheng R, Baade PD, et al.Cancer statistics in China, 2015[J].CA Cancer J Clin, 2016, 66(2): 115-32. doi: 10.3322/caac.21338
[2] McGale P, Darby SC, Hall P, et al.Incidence of heart disease in 35, 000 women treated with radiotherapy for breast cancer in Denmark and Sweden[J].Radiother Oncol, 2011, 100(2): 167-75. doi: 10.1016/j.radonc.2011.06.016
[3] Darby SC, McGale P, Taylor CW, et al.Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300, 000 women in US SEER cancer registries[J].Lancet Oncol, 2005, 6(8): 557-65. doi: 10.1016/S1470-2045(05)70251-5
[4] Palumbo I, Palumbo B, Fravolini ML, et al.Brain natriuretic peptide as a cardiac marker of transient radiotherapy-related damage in left-sided breast cancer patients: A prospective study[J].Breast, 2016, 25: 45-50. doi: 10.1016/j.breast.2015.10.004
[5] D'Errico MP, Petruzzelli MF, Gianicolo EA, et al.Kinetics of B-type natriuretic peptide plasma levels in patients with left-sided breast cancer treated with radiation therapy: Results after one-year follow-up[J].Int J Radiat Biol, 2015, 91(10): 804-9. doi: 10.3109/09553002.2015.1027421
[6] D'Errico MP, Grimaldi L, Petruzzelli MF, et al.N-terminal pro-B-type natriuretic peptide plasma levels as a potential biomarker for cardiac damage after radiotherapy in patients with left-sided breast cancer[J].Int J Radiat Oncol Biol Phys, 2012, 82(2): e239-46. doi: 10.1016/j.ijrobp.2011.03.058
[7] Skyttä T, Tuohinen S, Boman E, et al.Troponin T-release associates with cardiac radiation doses during adjuvant left-sided breast cancer radiotherapy[J].Radiat Oncol, 2015, 10: 141. doi: 10.1186/s13014-015-0436-2
[8] 王月爱, 夏稻子.心肌背向散射积分参数评价左乳腺癌放疗早期心脏损伤[J].中国医学影像技术, 2006, 22(11): 1682-4. http://www.cnki.com.cn/Article/CJFDTOTAL-ZYXX200611022.htm Wang YA, Xia DZ.Integrated backscatter parameters in assessment of early myocardial damage induced by left breast cancer radiotherapy[J].Zhongguo Yi Xue Ying Xiang Ji Shu, 2006, 22(11): 1682-4. http://www.cnki.com.cn/Article/CJFDTOTAL-ZYXX200611022.htm
[9] 万里凯, 张琴, 张雅莉, 等.左乳腺癌调强放射治疗前后彩色多普勒超声心动图的对比研究[J].中国临床新医学, 2015, 11: 1022-4. http://www.cnki.com.cn/Article/CJFDTOTAL-ZYLN201511005.htm Wan LK, Zhang Q, ZhangYL, et al.The self-control study of echocardiography on patients with left breast cancer received IMRT[J].Zhongguo Lin Chuang Xin Yi Xue, 2015, 11: 1022-4. http://www.cnki.com.cn/Article/CJFDTOTAL-ZYLN201511005.htm
[10] Finch W, Shamsa K, Lee MS.Cardiovascular complications of radiation exposure[J].Rev Cardiovasc Med, 2014, 15(3): 232-44. https://www.researchgate.net/publication/266626071_Cardiovascular_Complications_of_Radiation_Exposure?_sg=7HMfJprbGd9KenJQjFl_70QYQ-YGvINNu15FjSi1t9CZkH7niGlUlVtPSH0VJ351Aq3NKaLbw9dwGBCB5ePIXQ
[11] Darby SC, Ewertz M, McGale P, et al.Risk of ischemic heart disease in women after radiotherapy for breast cancer[J].N Engl J Med, 2013, 368(11): 987-98. doi: 10.1056/NEJMoa1209825
[12] 何宏涛, 王军, 刘青, 等.急性放射性心脏损伤剂量体积因素分析[J].中华肿瘤防治杂志, 2014, 21(10): 767-70. http://www.cnki.com.cn/Article/CJFDTOTAL-QLZL201410014.htm He HT, Wang J, Liu Q, et al.Dose and volume factors to the acute radiation-induced heart diseas[J].Zhonghua Zhong Liu Fang Zhi Za Zhi, 2014, 21(10): 767-70. http://www.cnki.com.cn/Article/CJFDTOTAL-QLZL201410014.htm
[13] 陈文奕, 罗文高, 杨玉成, 等.胸部恶性肿瘤放射治疗致放射性心包炎的预防及治疗[J].海南医学, 2006, 17(8): 85. http://www.cnki.com.cn/Article/CJFDTOTAL-HAIN200608058.htm Chen WY, Luo WG, Yang YC, et al.The prevention and treatment of radioactive pericarditis in thoracic cancer radiotherapy[J].HainanYi Xue, 2006, 17(8): 85. http://www.cnki.com.cn/Article/CJFDTOTAL-HAIN200608058.htm
[14] Wollschläger D, Karle H, Stockinger M, et al.Radiation dose distribution in functional heart regions from tangential breast cancer radiotherapy[J].Radiother Oncol, 2016, 119(1): 65-70. doi: 10.1016/j.radonc.2016.01.020
[15] Evans ES, Prosnitz RG, Yu X, et al.Impact of patient-specific factors, irradiated left ventricular volume, and treatment set-up errors on the development of myocardial perfusion defects after radiation therapy for left-sided breast cancer[J].Int J Radiat Oncol Biol Phys, 2006, 66(4): 1125-34. doi: 10.1016/j.ijrobp.2006.06.025
[16] Topolnjak R, Borst GR, Nijkamp J, et al.Image-guided radiotherapy for left-sided breast cancer patients: geometrical uncertainty of the heart[J].Int J Radiat Oncol Biol Phys, 2012, 82(4): e647-55. doi: 10.1016/j.ijrobp.2011.08.024
[17] Guan H, Dong YL, Ding LJ, et al.Morphological factors and cardiac doses in whole breast radiation for left-sided breast cancer[J].Asian Pac J Cancer Prev, 2015, 16(7): 2889-94. doi: 10.7314/APJCP.2015.16.7.2889
[18] Tanaka H, Hayashi S, Hoshi H.Cardiac counterclockwise rotation is a risk factor for high-dose irradiation to the left anterior descending coronary artery in patients with left-sided breast cancer who receiving adjuvant radiotherapy after breast-conserving surgery[J].Nagoya J Med Sci, 2014, 76(3-4): 265-72. https://www.researchgate.net/publication/273155449_Cardiac_counterclockwise_rotation_is_a_risk_factor_for_high-dose_irradiation_to_the_left_anterior_descending_coronary_artery_in_patients_with_left-sided_breast_cancer_who_receiving_adjuvant_radiothera?_sg=ZU1zwy67ZS0IqxxvG7LVpxip0cyLjuagGr2-ozj3XMTzViuuCpKTpnDey8pf_zEoq0mjtv4GKkSCNK5fAB1MLg
[19] Zhang L, Mei X, Chen X, et al.Estimating cardiac substructures exposure from diverse radiotherapy techniques in treating left-sided breast cancer[J].Medicine (Baltimore), 2015, 94(18): e847. doi: 10.1097/MD.0000000000000847
[20] 刘旭红, 陈晓, 李文辉, 等.切线半束"野中野"正向调强在乳腺癌保乳术后放射治疗中的应用[J].医疗装备, 2015, 4: 17-8, 9. http://www.cnki.com.cn/Article/CJFDTOTAL-YLZB201504011.htm Liu XH, Chen X, Li WH, et al.The application of half tangent " field in field" positive intensity-modulated radiotherapy in postoperative breast cancer[J].Yi Liao Zhuang Bei, 2015, 4: 17-8, 9. http://www.cnki.com.cn/Article/CJFDTOTAL-YLZB201504011.htm
[21] Wang J, Li X, Deng Q, et al.Postoperative radiotherapy following mastectomy for patients with left-sided breast cancer: A comparative dosimetric study[J].Med Dosim, 2015, 40(3): 190-4. doi: 10.1016/j.meddos.2014.11.004
[22] Ma C, Zhang W, Lu J, et al.Dosimetric Comparison and Evaluation of Three Radiotherapy Techniques for Use after Modified Radical Mastectomy for Locally Advanced Left-sided Breast Cancer[J].Sci Rep, 2015, 5: 12274. doi: 10.1038/srep12274
[23] Virén T, Heikkilä J, Myllyoja K, et al.Tangential volumetric modulated arc therapy technique for left-sided breast cancer radiotherapy[J].Radiat Oncol, 2015, 10: 79. doi: 10.1186/s13014-015-0392-x
[24] Pasler M, Lutterbach J, Bjornsgard M, et al.VMAT techniques for lymph node-positive left sided breast cancer[J].Z Med Phys, 2015, 25(2): 104-11. doi: 10.1016/j.zemedi.2014.03.008
[25] Jin GH, Chen LX, Deng XW, et al.A comparative dosimetric study for treating left-sided breast cancer for small breast size using five different radiotherapy techniques: conventional tangential field, filed-in-filed, tangential-IMRT, multi-beam IMRT and VMAT[J].Radiat Oncol, 2013, 8: 89. doi: 10.1186/1748-717X-8-89
[26] Chen JL, Cheng JC, Kuo SH, et al.Prone breast forward intensity-modulated radiotherapy for Asian women with early left breast cancer: factors for cardiac sparing and clinical outcomes[J].J Radiat Res, 2013, 54(5): 899-908. doi: 10.1093/jrr/rrt019
[27] Qi XS, Liu TX, Liu AK, et al.Left-sided breast cancer irradiation using rotational and fixed-field radiotherapy[J].Med Dosim, 2014, 39(3): 227-34. doi: 10.1016/j.meddos.2014.02.005
[28] Pasler M, Georg D, Bartelt S, et al.Node-positive left-sided breast cancer: does VMAT improve treatment plan quality with respect to IMRT?[J].Strahlenther Onkol, 2013, 189(5): 380-6. doi: 10.1007/s00066-012-0281-2
[29] Haertl PM, Pohl F, Weidner K, et al.Treatment of left sided breast cancer for a patient with funnel chest: volumetric-modulated arc therapy vs.3D-CRT and intensity-modulated radiotherapy[J].Med Dosim, 2013, 38(1): 1-4. doi: 10.1016/j.meddos.2012.04.003
[30] Chan TY, Tan PW, Tan CW, et al.Assessing radiation exposure of the left anterior descending artery, heart and lung in patients with left breast cancer: A dosimetric comparison between multicatheter accelerated partial breast irradiation and whole breast external beam radiotherapy[J].Radiother Oncol, 2015, 117(3): 459-66. doi: 10.1016/j.radonc.2015.08.013
[31] Hayden AJ, Rains M, Tiver K.Deep inspiration breath hold technique reduces heart dose from radiotherapy for left-sided breast cancer[J].J Med Imaging Radiat Oncol, 2012, 56(4): 464-72. doi: 10.1111/jmiro.2012.56.issue-4
[32] Tanguturi SK, Lyatskaya Y, Chen Y, et al.Prospective assessment of deep inspiration breath-hold using 3-dimensional surface tracking for irradiation of left-sided breast cancer[J].Pract Radiat Oncol, 2015, 5(6): 358-65. doi: 10.1016/j.prro.2015.06.002
[33] Register S, Takita C, Reis I, et al.Deep inspiration breath-hold technique for left-sided breast cancer: An analysis of predictors for organ-at-risk sparing[J].Med Dosim, 2015, 40(1): 89-95. doi: 10.1016/j.meddos.2014.10.005
[34] Hepp R, Ammerpohl M, Morgenstern C, et al.Deep inspiration breath-hold (DIBH) radiotherapy in left-sided breast cancer: Dosimetrical comparison and clinical feasibility in 20 patients[J].Strahlenther Onkol, 2015, 191(9): 710-6. doi: 10.1007/s00066-015-0838-y
[35] Chi F, Wu S, Zhou J, et al.Dosimetric comparison of moderate deep inspiration breath-hold and free-breathing intensity-modulated radiotherapy for left-sided breast cancer[J].Cancer radiother, 2015, 19(3): 180-6. doi: 10.1016/j.canrad.2015.01.003
[36] Swamy ST, Radha CA, Kathirvel M, et al.Feasibility study of deep inspiration breath-hold based volumetric modulated arc therapy for locally advanced left sided breast cancer patients[J].Asian Pac J Cancer Prev, 2014, 15(20): 9033-8. doi: 10.7314/APJCP.2014.15.20.9033
[37] Bolukbasi Y, Saglam Y, Selek U, et al.Reproducible deep-inspiration breath-hold irradiation with forward intensity-modulated radiotherapy for left-sided breast cancer significantly reduces cardiac radiation exposure compared to inverse intensity-modulated radiotherapy[J].Tumori, 2014, 100(2): 169-78. https://www.researchgate.net/publication/262582141_Reproducible_deep-inspiration_breath-hold_irradiation_with_forward_intensity-modulated_radiotherapy_for_left-sided_breast_cancer_significantly_reduces_cardiac_radiation_exposure_compared_to_inverse_in
[38] Reardon KA, Read PW, Morris MM, et al.A comparative analysis of 3D conformal deep inspiratory-breath hold and free-breathing intensity-modulated radiation therapy for left-sided breast cancer[J].Med Dosim, 2013, 38(2): 190-5. doi: 10.1016/j.meddos.2013.01.002
[39] Mast ME, van Kempen-Harteveld L, Heijenbrok MW, et al.Left-sided breast cancer radiotherapy with and without breath-hold: does IMRT reduce the cardiac dose even further?[J].Radiother Oncol, 2013, 108(2): 248-53. doi: 10.1016/j.radonc.2013.07.017
[40] Alderliesten T, Betgen A, Elkhuizen PH, et al.Estimation of heart-position variability in 3D-surface-image-guided deep-inspiration breath-hold radiation therapy for left-sided breast cancer[J].Radiother Oncol, 2013, 109(3): 442-7. doi: 10.1016/j.radonc.2013.09.017
[41] Yeung R, Conroy L, Long K, et al.Cardiac dose reduction with deep inspiration breath hold for left-sided breast cancer radiotherapy patients with and without regional nodal irradiation[J].Radiat Oncol, 2015, 10: 200. doi: 10.1186/s13014-015-0511-8
[42] Kathpal M, Tinnel B, Sun K, et al.Deep inspiration breath hold with electromagnetic confirmation of chest wall position for adjuvant therapy of left-sided breast cancer: Technique and accuracy[J].Pract Radiat Oncol, 2016, 6(5): e195-202. doi: 10.1016/j.prro.2015.12.008
[43] Yang W, McKenzie EM, Burnison M, et al.Clinical experience using a video-guided spirometry system for deep inhalation breath-hold radiotherapy of left-sided breast cancer[J].J Appl Clin Med Phys, 2015, 16(2): 5218.
[44] McIntosh A, Shoushtari AN, Benedict SH, et al.Quantifying the reproducibility of heart position during treatment and corresponding delivered heart dose in voluntary deep inhalation breath hold for left breast cancer patients treated with external beam radiotherapy[J].Int J Radiat Oncol Biol Phys, 2011, 81(4): e569-76. doi: 10.1016/j.ijrobp.2011.01.044
[45] Lin LL, Vennarini S, Dimofte A, et al.Proton beam versus photon beam dose to the heart and left anterior descending artery for left-sided breast cancer[J].Acta Oncol, 2015, 54(7): 1032-9. doi: 10.3109/0284186X.2015.1011756
[46] Cammarota F, Giugliano FM, Iadanza L, et al.Hypofractionated breast cancer radiotherapy.Helical tomotherapy in supine position or classic 3D-conformal radiotherapy in prone position: which is better?[J].Anticancer Res, 2014, 34(3): 1233-8. http://ar.iiarjournals.org/content/34/3/1233.short
[47] Würschmidt F, Stoltenberg S, Kretschmer M, et al.Incidental dose to coronary arteries is higher in prone than in supine whole breast irradiation.A dosimetric comparison in adjuvant radiotherapy of early stage breast cancer[J].Strahlenther Onkol, 2014, 190(6): 563-8. doi: 10.1007/s00066-014-0606-4
[48] 高艳, 李先明, 钟鹤立, 等.乳腺癌保乳术后俯卧位与仰卧位放疗危及器官剂量比较的Meta分析[J].肿瘤防治研究, 2015, 42(9): 905-10. http://www.zlfzyj.com/CN/abstract/abstract8588.shtml Gao Y, Li XM, Zhong HL, et al.Dosimetric comparison between prone and supine positions in radiotherapy on organs at risk after breast-conserving surgery: a Meta-analysis[J].Zhong Liu Fang Zhi Yan Jiu, 2015, 42(9): 905-10. http://www.zlfzyj.com/CN/abstract/abstract8588.shtml
[49] Cao L, Cai G, Chang C, et al.Early cardiac toxicity following adjuvant radiotherapy of left-sided breast cancer with or without concurrent trastuzumab[J].Oncotarget, 2016, 7(1): 1042-54.
[50] Skyttä T, Tuohinen S, Virtanen V, et al.The concurrent use of aromatase inhibitors and radiotherapy induces echocardiographic changes in patients with breast cancer[J].Anticancer Res, 2015, 35(3): 1559-66. https://www.researchgate.net/publication/273324120_The_Concurrent_Use_of_Aromatase_Inhibitors_and_Radiotherapy_Induces_Echocardiographic_Changes_in_Patients_with_Breast_Cancer
[51] Magné N, Castadot P, Chargari C, et al.Special focus on cardiac toxicity of different sequences of adjuvant doxorubicin/docetaxel/CMF regimens combined with radiotherapy in breast cancer patients[J].Radiother Oncol, 2009, 90(1): 116-21. doi: 10.1016/j.radonc.2008.10.003
[52] Chan EK, Woods R, Virani S, et al.Long-term mortality from cardiac causes after adjuvant hypofractionated vs.conventional radiotherapy for localized left-sided breast cancer[J].Radiother Oncol, 2015, 114(1): 73-8. doi: 10.1016/j.radonc.2014.08.021
[53] Prosnitz RG, Hubbs JL, Evans ES, et al.Prospective assessment of radiotherapy-associated cardiac toxicity in breast cancer patients: analysis of data 3 to 6 years after treatment[J].Cancer, 2007, 110(8): 1840-50. doi: 10.1002/(ISSN)1097-0142
[54] Henson KE, McGale P, Taylor C, et al.Radiation-related mortality from heart disease and lung cancer more than 20 years after radiotherapy for breast cancer[J].Br J Cancer, 2013, 108(1): 179-82. doi: 10.1038/bjc.2012.575
计量
- 文章访问数: 1977
- HTML全文浏览量: 322
- PDF下载量: 1629
下载:
